Pirow Bekker
- Orthopedics and Sports Medicine top 0.2%
- Bone health and osteoporosis research 8
- Oncology top 0.5%
- Bone health and treatments 22
- Chemokine receptors and signaling 9
- Nephrology top 1%
- Renal Diseases and Glomerulopathies 6
- Rheumatology top 0.5%
- Otitis Media and Relapsing Polychondritis 7
- Immunology top 2%
-
- Vasculitis and related conditions 20
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 13
-
- Bone Metabolism and Diseases 9
- Co-authors
- Donna HollowayThomas J. SchallDavid JayneColin R. DunstanPhilip T. LeesePeter A. MerkelStanley CohenMark Peterson
- Journals
- New England Journal of Medicine (2 papers)Journal of Clinical Oncology (3 papers)Gastroenterology (3 papers)
- Partner nations
- United StatesUnited KingdomSweden
In The Last Decade
Pirow Bekker
75 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Orthopedics and Sports Medicine 1.6k
- Oncology 3.0k
- Nephrology 648
- Rheumatology 1.2k
- Immunology 1.2k
Countries citing papers authored by Pirow Bekker
This map shows the geographic impact of Pirow Bekker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pirow Bekker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pirow Bekker more than expected).
Fields of papers citing papers by Pirow Bekker
This network shows the impact of papers produced by Pirow Bekker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pirow Bekker. The network helps show where Pirow Bekker may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pirow Bekker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 10 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 46 | |
| 6 | Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitisbreakdown → | 2017 | 420 |
| 7 | 2016 | 115 | |
| 8 | 2015 | 18 | |
| 9 | 2015 | 220 | |
| 10 | Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis | 2014 | 4 |
| 11 | 2013 | 110 | |
| 12 | 2012 | 76 | |
| 13 | 2010 | 130 | |
| 14 | MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B | 2008 | 1 |
| 15 | 2007 | 1 | |
| 16 | 2006 | 16 | |
| 17 | Denosumab in Postmenopausal Women with Low Bone Mineral Densitybreakdown → | 2006 | 886 |
| 18 | 2004 | 385 | |
| 19 | 1994 | 13 | |
| 20 | 1993 | 22 |
About Pirow Bekker
Pirow Bekker is a scholar working on Genetics, Oncology and Orthopedics and Sports Medicine, having authored 76 papers that have together received 5.8k indexed citations. Recurring topics across this work include Bone health and treatments (22 papers), Vasculitis and related conditions (20 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (13 papers), Chemokine receptors and signaling (9 papers), Bone Metabolism and Diseases (9 papers), Bone health and osteoporosis research (8 papers), Otitis Media and Relapsing Polychondritis (7 papers) and Renal Diseases and Glomerulopathies (6 papers). The work is most often cited by research in Orthopedics and Sports Medicine (1.6k citations), Oncology (3.0k citations) and Nephrology (648 citations). Pirow Bekker has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Donna Holloway, Thomas J. Schall, David Jayne, Colin R. Dunstan, Philip T. Leese, Peter A. Merkel, Stanley Cohen, Mark Peterson, Steven W. Martin and Paul D. Miller. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.